![]() |
|
|
Vol. 59, Issue 1, 16-23, January 2001
Department of Physiology & Cell Biology, University of Nevada School of Medicine, Reno, Nevada
| |
Abstract |
|---|
|
|
|---|
Epoxyeicosatrienoic acids (EETs) are arachidonic acid metabolites
of cytochrome P450 monooxygenase, which are released from endothelial
cells and dilate arteries. Dilation seems to be caused by activation of
large-conductance Ca2+-activated K+ channels
(BKCa) leading to membrane hyperpolarization. Previous studies suggest that EETs activate BKCa channels via
ADP-ribosylation of the G protein G
s with a subsequent
membrane-delimited action on the channel [Circ Res
78:415-423, 1996; 80:877-884, 1997;
85:349-356, 1999]. The present study examined whether this
pathway is present in human embryonic kidney (HEK) 293 cells when the
BKCa
-subunit (cslo-
) is
expressed without the
-subunit. 11,12-EET increased outward
K+ current in whole-cell recordings of HEK293
cells. In cell-attached patches, 11,12-EET also increased the activity
of cslo-
channels without affecting unitary conductance.
This action was mimicked by cholera toxin. The ADP-ribosyltransferase
inhibitors 3-aminobenzamide and m-iodobenxylguanidine
blocked the stimulatory effect of 11,12-EET. In inside-out patches
11,12-EET was without effect on channel activity unless GTP was
included in the bathing solution. GTP and GTP
S alone also activated
cslo-
channels. Dialysis of cells with anti-G
s
antibody completely blocked the activation of cslo-
channels by 11,12-EET, whereas anti-G
i/o and anti-G
antibodies were without effect. The protein kinase A inhibitor KT5720 and the
adenylate cyclase inhibitor SQ22536 did not reduce the stimulatory effect of 11,12-EET on cslo-
channels in cell-attached
patches. These data suggest that EET leads to G
s-dependent
activation of the cslo-
subunits expressed in HEK293
cells and that the cslo-
subunit is not required.
| |
Introduction |
|---|
|
|
|---|
The
vascular endothelium modulates tone of the underlying smooth muscle by
releasing a number of different contracting and relaxing factors. Among
these, endothelin, nitric oxide, and prostacyclin have been
particularly well characterized (Furchgott and Vanhoutte, 1989
). Recent
studies suggest that an additional factor [i.e., epoxyeicosatrienoic
acid (EET)], which is a product of the cytochrome P450 pathway, is
also synthesized and released from the endothelium (Bauersachs et al.,
1994
; Hecker et al., 1994
; Campbell et al., 1996
). Endothelial cells
possess cytochrome monooxygenase activity (Abraham et al., 1985
; Pinto
et al., 1987
; Rosolowsky et al., 1990
), and several cytochrome P450
isoforms have been described in endothelial cells. In vitro studies
have shown that EETs relax coronary, pial, cerebral, caudal, and renal
arteries; in some studies, membrane hyperpolarization has been observed
(Hecker et al., 1994
; Campbell et al., 1996
; Fukao et al., 1997
; Eckman et al., 1998
). These results suggest that EETs contribute to
endothelium-dependent relaxation and hyperpolarization in some blood vessels.
The vasodilatory action of EET seems to be due in large part to
activation of large conductance Ca2+-activated K
channels (BKCa). Patch-clamp studies have shown
that EETs increase the open probability of BKCa
channels in native cells (Campbell et al., 1996
; Li and Campbell, 1997
;
Hayabuchi et al., 1998
). Membrane potential measurements in intact
blood vessels have reported that EET-induced hyperpolarization is
blocked by the BKCa channel blocker iberiotoxin
(Eckman et al., 1998
). Finally, EET-induced relaxation can be reduced
or abolished by either iberiotoxin or tetraethylammonium
(Campbell et al., 1996
; Li and Campbell, 1997
; Eckman et al., 1998
; Li
et al., 1999
). Previous studies of native cells suggest that EETs
enhance BKCa activity by activating the G protein
G
s (Li and Campbell, 1997
) via ADP-ribosylation (Li et al.,
1999
). Some studies suggest that this is a direct membrane-delimited
action of G
s on the channel (Campbell et al., 1996
; Li and
Campbell, 1997
).
Many details concerning the mechanism by which EETs modulate
BKCa channel activity remain unclear. For
example, a specific receptor for EETs has yet to be positively
identified. Furthermore, the mechanism by which the G protein
G
s leads to activation of the BKCa
channel activity is unknown. It is possible that G protein subunits
interact specifically with the
-subunit of the
BKCa channel. Alternatively, the
-subunit may
be involved in the process. Expression systems are particularly useful
to address these questions, because it is possible to express a known
isoform of the BKCa
-subunit in the absence of
the
-subunit and ultimately to manipulate with molecular biology
techniques the predicted components of the pathway. The goal of the
present study was therefore to determine whether the pathway previously
described for EET-induced modulation of BKCa
channels in native cells (Campbell et al., 1996
; Li and Campbell, 1997
;
Li et al., 1999
) is present when a known isoform of the
-subunit of
the BKCa channel is expressed in a mammalian expression system (i.e., HEK293 cells). In previous studies, we have
shown that BKCa
-subunits
(cslo-
) expressed in HEK293 cells give rise to
voltage-gated, Ca2+-sensitive currents with
electrophysiological and pharmacological features similar to those of
native BKCa (Adelman et al., 1992
; Esguerra et
al., 1994
; Perez et al., 1994
; Fukao et al., 1999
). Specific
experiments in this study were designed to determine whether: 1) EETs
enhance cslo-
channel activity in this expression system,
2) the G protein
s and/or 
subunit is involved, 3) activation
involves ADP-ribosylation, and 4) activation of cslo-
involves the adenylyl cyclase/protein kinase A (PKA) pathway or a
direct membrane-delimited pathway. Our results reveal a striking similarity in the pathway identified previously from experiments in
native vascular smooth muscle cells and the pathway present in HEK293
cells expressing cslo-
. These results suggest
that all of the elements necessary for the EET pathway are present in
HEK293 cells expressing cslo-
and that the
-subunit of
BKCa is not required for activation. This
expression system represents a promising model for future studies of
this important regulatory pathway.
| |
Materials and Methods |
|---|
|
|
|---|
Expression of cslo-
Channels.
The cDNA
encoding the
-subunit of the canine colonic
BKCa channel (cslo-
) was expressed
in HEK293 cells as described previously (Fukao et al., 1999
).
Electrophysiological Recording.
The patch-clamp technique
was used to measure membrane currents in whole-cell and isolated patch
configurations as previously described (Fukao et al., 1999
). Data
acquisition and analysis were performed with pClamp software (version
6.0.4; Axon Instruments, Burlingame, CA). Channel open probability
(NPo) in patches was determined from recordings
of more than 3 min by fitting the sum of Gaussian functions to an
all-points histogram plot at each potential. Single-channel conductance
was determined from all-point amplitude histograms using Fechan and
P-stat programs (Axon Instruments). Capacitance compensation and series
resistance compensation (80%) were performed.
Solutions and Drugs.
For whole-cell recordings of HEK293
cells, the bath solution contained 135 mM NaCl, 5 mM KCl, 1.8 mM
CaCl2, 1 mM MgCl2, 10 mM
HEPES, and 10 mM glucose, pH 7.4, and the pipette solution contained 50 mM KCl, 70 mM KAsp, 8 mM NaCl, 0.826 mM CaCl2, 1 mM MgCl2, 2 mM MgATP, 0.1 mM NaGTP, 10 mM HEPES,
and 1 mM HEDTA, pH 7.2. For single-channel recordings in the inside-out
mode, the bath solution contained 140 mM KCl, 1 mM
MgCl2, 10 mM HEPES, and 1 mM HEDTA, pH 7.2. The
concentration of free Ca2+ in the bath solution
was varied (range, 10
8 to
10
4 M) to determine the
Ca2+ sensitivity of BKCa
channels. The Ca2+ concentration was estimated by
a computer program (Bers et al., 1994
), and the appropriate amounts of
CaCl2 were added. The ionized Ca2+ concentration was confirmed using a
Ca2+-sensitive electrode. The pipette solution
contained 140 mM KCl, 1.8 mM CaCl2, 1 mM
MgCl2, 10 mM HEPES, pH 7.4. For single-channel recordings in the cell-attached mode, the bath solution contained 140 mM KCl, 1.8 mM CaCl2, 1 mM
MgCl2, 10 mM HEPES, and 10 mM glucose, pH 7.4, and the pipette solution contained 140 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, and 10 mM HEPES, pH 7.4. All patch-clamp experiments were performed at room
temperature (22°C). 11,12-EET was purchased from Cayman Chemical (Ann
Arbor, MI). KT5720, SQ22536, cholera toxin, and all antibodies were
obtained from Calbiochem (San Diego, CA). Anti-G
is a polyclonal
antibody raised against brain G
(catalog no. 371821).
Anti-G
i/o is a mixture of two antibodies: 1) Anti-G
i1 and G
i2
subunit antibody (catalog no. 371723) generated by using a synthetic
peptide antigen corresponding to a C-terminal decapeptide sequence
(345-354) found in both G
i1 and G
i2. 2) Anti-G
i3 and
G
o-subunit antibody (catalog no. 371726) generated by using a
synthetic peptide antigen corresponding to the C-terminal sequence
345-354 of G
i3. Anti-G
s antibody (catalog no. 371732) generated
by using a synthetic peptide antigen corresponding to the C-terminal
sequence 385-394 of G
s. 3-Aminobenzamide (3-AM) and
m-iodobenzylguanidine (MIBG) were obtained from Sigma
Chemical Co. (St. Louis, MO). 11,12-EET was dissolved in ethanol and
KT5720, forskolin in dimethyl sulfoxide. Solvent per se had no effect on channel activity at final concentration (ethanol, 0.03%; dimethyl sulfoxide, 0.1%).
Total RNA Isolation and Reverse Transcriptase-Polymerase Chain
Reaction.
Total RNA was prepared from human jejunum smooth muscle
and cultured HEK293 cells using the SNAP Total RNA isolation kit
(Invitrogen, San Diego, CA) as per the manufacturer's instructions.
First-strand cDNA was prepared from the RNA preparations using the
Superscript II reverse transcriptase kit (Life Technologies, Inc.,
Gaithersburg, MD), 500 µg/µl of oligo(dT) primers were used to
reverse transcribe the 1-µg RNA sample. The cDNA reverse
transcription product was amplified with
-slo-specific primers by
polymerase chain reaction (PCR) (Epperson et al., 1999
). The
amplification profile for these primer pairs was: 95°C for 10 min to
activate the amplitaq polymerase (PE Biosystems, Foster City, CA),
95°C for 15 s, and 60°C for 1 min; each for 40 cycles.
The amplified products (5 µl) were separated by electrophoresis on a
4% agarose/1× TAE (Tris, acetic acid, EDTA) gel, and the DNA bands
were visualized by ethidium bromide staining. The reverse transcriptase
control used a cDNA reaction as template for which the reverse
transcriptase was not added, controlling for genomic DNA contamination
in the source RNA. The no template control was a PCR amplification for
which the template was not added, controlling for nonspecific
amplification and spurious primer dimer fragments. These negative
controls were subjected to a second round of amplification to assure
specificity of the reactions and the quality of the reagents.
Primer Design.
The following PCR primers were used (the
GenBank accession numbers are given in parentheses for the reference
nucleotide sequences used): human
-slo (U25138)
nucleotides 199-218 and 376-397; amplicon = 199 base pairs (bp),
-actin (V01217) nucleotides 2204-2224 and 2384-2402; amplicon = 198 bp.
Statistics. Data are expressed as mean ± S.E. Statistical significance for repeated measures was determined using analysis of variance. P < 0.05 was considered significant.
| |
Results |
|---|
|
|
|---|
The endogenous currents of HEK293 cells and the currents recorded
in cells expressing cslo-
were previously characterized by this group using the whole-cell and inside-out excised patch configurations. Endogenous currents are much smaller in amplitude than
those recorded from cells expressing cloned cslo-
channels and thus do not significantly contaminate recordings (Fukao et al., 1999
).
Native HEK293 cells were examined for endogenous expression of
BKCa
subunit mRNA and compared with freshly
isolated human jejunal smooth muscle cells. Using primers designed to
hybridize to conserved regions of
-slo and
reverse-transcriptase PCR, no detectable product was observed in HEK293
cells, whereas an abundant message was detected in jejunal cells (Fig.
1). These results suggest that the
actions of EET on cslo-
subunits can be examined in
HEK293 cells in the absence of the cslo-
subunit.
|
Effect of 11,12-EET on Whole-Cell cslo-
Currents.
Experiments were undertaken to determine the action of
11,12-EET on cells expressing cslo-
using the whole-cell,
patch-clamp mode. Cytosolic Ca2+ concentration
was buffered at 10 µM with HEDTA in these experiments. Addition of
11,12-EET (1 µM) to the bathing solution led to a significant
increase in whole-cell outward current (Fig.
2A). Steady-state current was obtained
after approximately 5 min (Fig. 2B). A representative voltage-current
relationship of cslo-
current before and after treatment
of 11,12-EET is shown in Fig. 2C. In eight cells tested, 11,12-EET
significantly (P < 0.05) increased outward current
amplitude 2-fold at +50 mV (Fig. 2D).
|
Effect of 11,12-EET on cslo-
Channel
Activity in Cell-Attached Patches.
Additional experiments were
performed to determine whether changes also occur in single-channel
activity recorded in cell-attached patches. 11,12-EET increased
cslo-
channel activity in a concentration-dependent manner (Fig. 3A). 11,12-EET at
concentrations between 0.1 and 1 µM produced a 2- to 3.5-fold
increase in NPo of cslo-
channels (Fig. 3B) but had no effect on the unitary conductance [control, 238 ± 9.5; 11,12-EET (1 µM), 246 ± 10; n = 7, P > 0.05].
|
Effect of 11,12-EET on cslo-
Channel Activity in
Inside-Out Patches.
In contrast to the stimulatory effect of
11,12-EET on cslo-
channel in cell-attached patches,
11,12-EET did not significantly affect cslo-
channel
activity in inside-out patches when applied to the cytosolic surface of
the membrane (n = 12). The unitary conductance of
cslo-
channels was also unchanged by 11,12-EET in
inside-out patches (control, 247 ± 19; EET, 247 ± 10;
n = 11; P > 0.05). Because activation
of channels by 11,12-EET may involve phosphorylation, additional
experiments were undertaken with ATP. Application of ATP (1 mM) to the
bath solution had no effect on cslo-
channel activity
(n = 8). Likewise 11,12-EET was without effect in the
presence of ATP (n = 4). These results suggest that ATP
alone is insufficient to support activation of cslo-
channels by 11,12-EET in isolated patches.
Effect of GTP and GTP
S on cslo-
Channel
Activity in Inside-Out Patches.
There is evidence from native cell
experiments that EET can lead to activation of
BKCa channels via G
s (Li et al., 1997
). To
explore the role of G proteins in our expression system, additional experiments were undertaken with GTP and the nonhydrolyzable analogs GTP
S and GDP
S. GTP (100 µM) significantly increased
cslo-
channel activity in inside-out patches without
affecting the single-channel conductance (Fig.
4, A and B). In the presence of 100 µM
GTP, addition of 11,12-EET (1 µM) led to a further increase in
cslo-
channel activity (Fig. 4, A and B). These data
suggest that 11,12-EET activates cslo-
via a
GTP-dependent mechanism. GDP
S (200 µM), which inhibits
GTP-dependent pathways, did not affect the basal cslo-
channel activity in inside-out patches (Fig. 4D), but completely blocked the stimulatory effect of GTP as well as GTP plus 11,12-EET (Fig. 4B). The GTP analog GTP
S (10 µM) also increased channel activity of cslo-
in inside-out patches (Fig. 4, C and
D). This effect was also blocked by GDP
S (Fig. 4D).
|
Effect of Anti-G
s Antibody on the Stimulatory Effect of
11,12-EET on cslo-
Channels.
To further
investigate the nature of the GTP-dependent response, antibodies to
various G proteins were tested in experiments using the whole-cell
configuration. Specific antibodies against G
s, G
i/o, and G
were included in the pipette solution to inhibit the effects of these G
protein subunits. After obtaining a stable whole-cell current,
11,12-EET was added to the bathing solution to activate
cslo-
channels. There was no significant difference in
the ability of 11,12-EET to stimulate cslo-
current in
the presence of anti-G
i/o or anti-G
antibodies. In contrast,
11,12-EET was without effect on cslo-
current
in the presence of anti-G
s antibody (Fig.
5A), suggesting that 11,12-EET activated
cslo-
via G
s.
|
Effect of Cholera Toxin on cslo-
Channel Activity
in Cell-Attached Patches.
To provide further evidence for coupling
of G
s to cslo-
channels, we tested cholera toxin
(CTX), which activates G
s by ADP-ribosylation (Hopkins et al.,
1988
). Inclusion of CTX in the bathing solution gave rise to a
significant increase in cslo-
channel activity in
cell-attached patches (Fig. 5B) without a change in single-channel
conductance (control, 248 ± 13 pS; cholera toxin, 250 ± 12 pS; n = 8). In the presence of CTX, 11,12-EET did not
produce a further increase cslo-
channel activity (Fig. 5B).
Effect of Mono-ADP-ribosyltransferase Inhibitors on the
Stimulatory Effect of 11,12-EET on cslo-
Channels.
A recent study by Li et al. (1999)
has suggested that
activation of native BKCa channels by EET
involves ADP-ribosylation of G
s. To determine whether this same
pathway is present in HEK293 cells, we investigated the effect of two
different inhibitors of mono-ADP-ribosyltransferase, 3-aminobenzamide
(Purnell and Whish, 1980
) and m-iodobenzylguanidine (Smets
et al., 1990
). 3-AM (1 mM) did not affect basal channel activity in
cell-attached patches. However, in the presence of 3-AM the stimulatory
effect of 11,12-EET (1 µM) was abolished. Likewise, MIBG (100 µM)
was without effect on basal channel activity but blocked the
stimulatory effect of 11,12-EET on cslo-
channels (Fig.
5C).
Effect of KT5720 and SQ22536 on the Stimulatory Effect of 11,12-EET
on cslo-
Channels.
Our results suggest that
11,12-EET activates BKCa via ADP-ribosylation of
the G protein G
s. G
s is a well known activator of the adenylyl
cyclase/PKA pathway. To investigate the role of this pathway in the
actions of G
s and 11,12-EET, additional experiments were undertaken
with blockers of this pathway. The PKA inhibitor KT5720 (200 nM) was
without effect on basal cslo-
channel activity in
cell-attached patches (Fig. 6). In
addition, the stimulatory effect of 11,12-EET on cslo-
channel was not inhibited by pretreatment with KT5720 (Fig. 6, A and
B). In contrast, KT5720 completely abolished the stimulatory effect of
the adenylyl cyclase activator forskolin on cslo-
channels (Fig. 6B). The adenylate cyclase inhibitor SQ22536 (200 µM) was also without affect on basal cslo-
channel activity (Fig. 6C) in cell-attached patches. Stimulation of
BKCa channels by either 11,12-EET or cholera
toxin was unchanged in the presence of SQ22536 (Fig. 6C). These results
indicate that the adenylyl cyclase/PKA pathway is present in HEK293
cells but that this pathway cannot represent the predominant mechanism
by which 11,12-EET and G
s activate cslo-
channels.
|
| |
Discussion |
|---|
|
|
|---|
11,12-EET is a cytochrome P450 product of the arachidonic acid
cascade that is synthesized and released by the vascular endothelium and may serve as one of several different endothelium-derived factors,
which relax and hyperpolarize the adjacent smooth muscle (Bauersachs et
al., 1994
; Hecker et al., 1994
; Campbell et al., 1996
). In the present
study we found that 11,12-EET leads to activation of the cloned
-subunit of the BKCa channel
(cslo-
) when expressed in HEK293 cells. This activation
involves a novel pathway in which 11,12-EET leads to ADP-ribosylation
of the G protein G
s. G
s in turn activates cslo-
via
a membrane-delimited pathway that is independent of PKA and may involve
a direct action of G
s on the channel.
A number of studies have suggested that EETs relax blood vessels by
activating BKCa channels in the smooth muscle
(Hecker et al., 1994
; Campbell et al., 1996
; Li et al., 1997
; Eckman et al., 1998
). In the present study, 11,12-EET stimulated outward cslo-
current in whole-cell recordings and enhanced the
activity of cslo-
channels in cell-attached patches
without a change in single-channel conductance. The sensitivity of
cloned cslo-
channels to 11,12-EET (i.e., 0.1 µM EET)
was between that reported for native BKCa
channels of large arteries (i.e., 0.3-10 µM EET) (Gebremedhin et
al., 1992
; Hu and Kim, 1993
; Eckman et al., 1998
) and that of small
arteries (1 nM EET) (Li and Campbell, 1997
). At present, it is not
known what factors contribute to these differences in sensitivity.
The
-slo subunit has been cloned from a variety of tissue sources
and species. All are derived from the same gene and exhibit very
similar amino acid and nucleotide sequences across species. Northern
blot analysis using a cDNA probe containing the conserved core region
of cslo-
has revealed that cslo-
transcripts are ubiquitously expressed in a number of canine vascular
muscles, including portal vein, renal artery, and pulmonary artery
(Vogalis et al., 1996
). Various splice forms have been detected at the transcriptional level, some of which are expressed with tissue specificity. It is not clear to what extent the complete form and the
various splice forms are utilized translationally to form functional
BKCa channels in any smooth muscle. In the only complete description of
-slo in artery to date, Salkoff and coworkers detected two alternatively spliced forms of
-slo in human aorta and
umbilicus as well as the complete
-slo sequence (McCobb et al.,
1995
). However, no functional differences between the three forms of
-slo were observed when expressed in oocytes or Chinese hamster
ovary cells. Neither of the splice variants described by McCobb et al.
(1995)
were detected in canine colon (Vogalis et al., 1996
). The
cslo-
clone used in the present study is equivalent to
the full-length hslo 1.1 form from McCobb et al. (1995)
.
Using this molecular form we were able to mimic the actions of
11,12-EET and G
s previously described for native vascular
BKCa channels, suggesting that
cslo-
is functionally indistinguishable from the form(s)
expressed in vascular muscles, which give rise to the EET response.
GTP per se, as well as the nonhydrolyzable analog GTP
S, gave rise to
a significant increase in cslo-
channel activity that was
blocked by GDP
S. These data suggest that the predominant action of G
proteins on cslo-
channels in HEK293 cells is
stimulatory. In the presence of GTP, 11,12-EET caused a significant
increase in channel activity, and this effect was also blocked by
GDP
S. In contrast, in the absence of GTP, 11,12-EET was without
effect. Thus, 11,12-EET seems to activate channels via a GTP-dependent mechanism. Because anti-G
s antibody but not anti-Gi/o or
anti-G
antibodies blocked the actions of 11,12-EET, this suggests
that 11,12-EET stimulates cslo-
via the GTP-binding
protein G
s. The known G
s activator cholera toxin also enhanced
BKCa channel activity, providing additional
evidence for coupling between G
s and cslo-
channels.
This conclusion is in agreement with previous studies of 11,12-EET in
native bovine coronary artery cells (Li and Campbell, 1997
).
Recently it has been suggested that 11,12-EET can activate
mono-ADP-ribosyltransferase, which leads to the transfer of ADP-ribose to the 52-kDa G protein G
s, resulting in activation of
BKCa channels in small bovine coronary arteries
(Li et al., 1999
). A similar result was previously reported for EET in
the rat liver (Seki et al., 1992
). In agreement with these data, we
observed that the stimulatory effect of 11,12-EET on
cslo-
was blocked by two different
mono-ADP-ribosyltransferase inhibitors, 3-AM and MIBG. This suggests
that ADP-ribosylation of Gs
is also important in the regulation of
the cloned
-subunit of BKCa by 11,12-EET. The pathway by which 11,12-EET leads to activation of
mono-ADP-ribosyltransferase remains unclear. A high-affinity binding
site for 14(R),15(S)-EET in guinea pig
mononuclear membranes has been reported, suggesting that a receptor for
EET may exist (Wong et al., 1993
). Thus, 11,12-EET may stimulate
specific receptors that activate mono-ADP-ribosyltransferase, leading
to ADP-ribosylation of G
s. Interestingly, this action mimics cholera
toxin, which is an exogenous ADP-ribosyltransferase that also activates
G
s by ADP-ribosylation (Hopkins et al., 1988
).
In both native cell experiments and in expression systems there is good
evidence that PKA activation leads to an increase in
BKCa channel activity (Standen and Quayle, 1998
)
via phosphorylation of serine 869 (Nara et al., 1998
). Indeed,
BKCa channel activity was increased in the
present study by the adenylyl cyclase activator forskolin. Inhibition
of this effect by the PKA inhibitor KT5720 implies the existence of a
functional adenylyl cyclase/PKA pathway in HEK293 cells, and we
considered the possibility that this pathway might contribute to the
G
s-dependent responses to 11,12-EET. However, in cell-attached
patches, the stimulatory effect of 11,12-EET was not blocked by either
the adenylyl cyclase inhibitor SQ22536 nor the PKA inhibitor KT 5720, providing direct evidence that the actions of 11,12-EET are independent
of the adenylyl cyclase/PKA pathway. This conclusion is in agreement
with a study by Campbell et al. (1996)
in which 11,12-EET was shown to
relax the bovine coronary artery without a significant change in tissue
levels of either cAMP or cGMP. In studies of native cells, EET
activates BKCa channels through a PKA-dependent
mechanism in renal arteries (Imig et al., 1999
), whereas in porcine
(Hayabuchi et al., 1998
) and bovine coronary arteries (Campbell et al.,
1996
) a PKA-independent pathway has been proposed. Multiple isoforms of
adenylate cyclase and PKA exist (Houslay and Milligan, 1997
). The
variable role of PKA in the actions of EET may be related to: 1) the
presence of different isoforms of adenylyl cyclase and PKA in different cells, 2) the quantity of isoforms present, and 3) the degree of
coupling between G
s and adenylyl cyclase. In HEK293 cells the
membrane-delimited actions of G
s seem to far outweigh those of the
adenylyl cyclase/PKA pathway, because SQ22536 was also without effect
on cholera toxin, which activates all G
s within the cell. This
suggests very poor coupling between G
s and adenylyl cyclase in these
cells. Thus, in HEK293 cells, 11,12-EET seems to stimulate
cslo-
via a direct membrane-delimited action of G
s.
The nature of this interaction between channel and G protein requires
further investigation but seems to involve ADP-ribosylation of G
s.
BKCa channels play a fundamental role in the
regulation of membrane potential in smooth muscle, particularly under
circumstances where intracellular calcium is elevated (Brayden and
Nelson, 1992
). In recent years it has become apparent that the activity
of these channels can be importantly modulated by a variety of
different physiological stimuli, including EET. Native
BKCa channels are composed of pore-forming
-subunits (i.e.,
-slo) plus a regulatory
-subunit
[predominantly
1 in smooth muscle (Jiang et al., 1999
)] raising
the possibility that the
-subunit plays a role in regulation of
BKCa channel activity by G
s. HEK293 cells
transfected with specific BKCa subunits provide
an excellent system to investigate this issue, because endogenous
currents in general are small and there are no endogenous
BKCa currents (Yu and Kerchner, 1998
; Fukao et
al., 1999
) or message encoding the cslo-
subunit.
Accordingly, we interpret our results as indicating the regulation of
cslo-
channels expressed in the absence of
-subunits.
Further evidence of the lack of
-subunits is that the voltage for
half-maximal activation of the expressed BKCa
currents with 10 µM free Ca2+ is +20 mV (Fukao
et al., 1999
), similar to values reported by others for activation of
the
-slo subunits in the absence of the
-slo subunits (Toro et al., 1998
)). Thus, the present
study suggests that 11,12-EET activates BKCa
channels through a direct action on the
-subunit independent of the
-subunit. However, we do not rule out a modulatory role for the
subunit in this process.
In summary, we have shown that the cslo-
expressed in
HEK293 cells is activated by 11,12-EET in both the whole-cell and
single-channel configuration. Activation involves ADP-ribosylation of
G
s but is independent of the adenylyl cyclase/PKA pathway,
suggesting a direct, membrane-delimited pathway. These results agree
well with previous studies of native cells (Campbell et al., 1996
; Li
and Campbell, 1997
; Li et al., 1999
) and suggest that the
-subunit of BKCa is not required for this pathway. The
HEK293 expression system seems to be a promising model for future
studies of this important regulatory pathway.
| |
Acknowledgments |
|---|
We are grateful to N. Horowitz for help with the cell cultures.
| |
Footnotes |
|---|
Received May 4, 2000; Accepted September 19, 2000
This work was supported by the Banyu Fellowships in Lipid Metabolism and Atherosclerosis, which are sponsored by Banyu Pharmaceutical Co., Ltd.; The Merck Company foundation (M.F.); National Institutes of Health Grant HL40399 (K.D.K.); and National Institute of Diabetes and Digestive and Kidney Diseases Grant 41315 (B.H.).
Send reprint requests to: Kathleen Keef, Ph.D., Department of Physiology & Cell Biology, University of Nevada, Reno, NV 89557. E-mail: kathy{at}physio.unr.edu
| |
Abbreviations |
|---|
EET, epoxyeicosatrienoic acid;
BKCa channel, large-conductance Ca2+-activated K+
channel;
HEK, human embryonic kidney;
PKA, protein kinase A;
NPo, channel open probability;
HEDTA, N-(2-hydroxyethyl)ethylenediaminetriacetic acid;
3-AM, 3-aminobenzamide;
MIBG, m-iodobenzylguanidine;
PCR, polymerase chain reaction;
bp, base pair(s);
GTP
S, guanosine
5'-3-O-(thio)triphosphate;
GDP
S, guanyl-5'-yl
thiophosphate;
CTX, cholera toxin.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
W. Yang, B. B. Holmes, V. R. Gopal, R. V. K. Kishore, B. Sangras, X.-Y. Yi, J. R. Falck, and W. B. Campbell Characterization of 14,15-Epoxyeicosatrienoyl-Sulfonamides as 14,15-Epoxyeicosatrienoic Acid Agonists: Use for Studies of Metabolism and Ligand Binding J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1023 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Spector and A. W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Carroll, A. B. Doumad, J. Li, M. K. Cheng, J. R. Falck, and J. C. McGiff Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway Am J Physiol Renal Physiol, July 1, 2006; 291(1): F155 - F161. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ye, W. Zhou, T. Lu, S. G. Jagadeesh, J. R. Falck, and H.-C. Lee Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1326 - H1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sakamoto, T. Nonomura, S. Ohya, K. Muraki, T. Ohwada, and Y. Imaizumi Molecular Mechanisms for Large Conductance Ca2+-Activated K+ Channel Activation by a Novel Opener, 12,14-Dichlorodehydroabietic Acid J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 144 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sade, K. Muraki, S. Ohya, N. Hatano, and Y. Imaizumi Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids Am J Physiol Cell Physiol, January 1, 2006; 290(1): C77 - C86. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Campbell, B. B. Holmes, J. R. Falck, J. H. Capdevila, and K. M. Gauthier Regulation of potassium channels in coronary smooth muscle by adenoviral expression of cytochrome P-450 epoxygenase Am J |